London · Delayed Price · Currency is GBP · Price in GBX Solvonis Therapeutics Statistics
Total Valuation
LON:SVNS has a market cap or net worth of GBP 20.15 million. The enterprise value is 18.50 million.
| Market Cap | 20.15M |
| Enterprise Value | 18.50M |
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LON:SVNS has 6.81 billion shares outstanding. The number of shares has increased by 2,177.31% in one year.
| Current Share Class | 6.81B |
| Shares Outstanding | 6.81B |
| Shares Change (YoY) | +2,177.31% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.90% |
| Owned by Institutions (%) | 46.88% |
| Float | 4.49B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.16 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.13 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -645.25 |
Financial Efficiency
Return on equity (ROE) is -60.51% and return on invested capital (ROIC) is -36.12%.
| Return on Equity (ROE) | -60.51% |
| Return on Assets (ROA) | -27.61% |
| Return on Invested Capital (ROIC) | -36.12% |
| Return on Capital Employed (ROCE) | -32.61% |
| Weighted Average Cost of Capital (WACC) | 12.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -861,667 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.79% in the last 52 weeks. The beta is 1.57, so LON:SVNS's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +55.79% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.26 |
| Relative Strength Index (RSI) | 55.34 |
| Average Volume (20 Days) | 34,187,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.58M |
| Pretax Income | -2.60M |
| Net Income | -2.59M |
| EBITDA | n/a |
| EBIT | -2.58M |
| Earnings Per Share (EPS) | -0.00 |
Balance Sheet
The company has 1.72 million in cash and 77,000 in debt, with a net cash position of 1.64 million or 0.00 per share.
| Cash & Cash Equivalents | 1.72M |
| Total Debt | 77,000 |
| Net Cash | 1.64M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 6.94M |
| Book Value Per Share | 0.00 |
| Working Capital | 204,000 |
Cash Flow
| Operating Cash Flow | -1.72M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:SVNS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,177.31% |
| Shareholder Yield | -2,177.31% |
| Earnings Yield | -12.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |